zepbound is glp 1 GLP1 Drug Use For Weight Loss Has Soared Costing Billions Zepbound vs Semaglutide GLP-1 vs

JAMA 314 , 557558 (2015)

The boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) should not use these medications

Alternative injection sites like the thigh or abdomen can be rotated systematically

Symptoms may include muscle weakness, irregular heartbeat, or confusion

For patients with BMI 30 or BMI 27 with weight-related health conditions, the long-term cardiovascular and metabolic benefits typically outweigh short-term GI discomfort